NCT01072565View on ClinicalTrials.gov

Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring

NACompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Type 2 Diabetes
Interventions
OTHER

SMBG to guide clinical decisions

The investigator will base clinical decisions on A1c and modal day analysis of SMBG.

OTHER

SMBG and CGM

The investigator will base clinical decisions on A1c, modal day analysis of SMBG and CGM data.

Trial Locations (1)

55416

International Diabetes Center, Minneapolis

Sponsors

Collaborators (1)

Abbott Diabetes Care
All Listed Sponsors
collaborator

International Diabetes Center at Park Nicollet

OTHER

collaborator

Abbott Diabetes Care

INDUSTRY

lead

HealthPartners Institute

OTHER